Clinical trials: Multidrug Resistance Tubercolosis
Multidrug Resistance Tubercolosis, Non Tubercolar Micobacteriosis
Endobronchial Valve in Tubercular and NTM Pulmonary Cavities.
Tuberculosis (TB) is a complex disease in which the lungs are the primary site of infection. Infection is acquired through inhalation of droplet nuclei laden with Mycobacterium bacilli (M.
- Trial name
- TBET (NCT07296055)
- Testing
- Endobronchial valves
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
Healthy Subjects
Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169
Open-label prospective non-comparative ascending dose randomized cohort study of single and multiple oral administration of PBTZ169 (capsules 80 mg) in healthy volunteers
- Trial name
- NCT04150224
- Testing
- PBTZ169 640 mg OD, PBTZ169 640 mg BiD, PBTZ169 960 mg SD
- Where
- Russia
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Nearmedic Plus LLC